Protection against lethal Sendai virus infection by in vivo priming of virus-specific cytotoxic T lymphocytes with a free synthetic peptide.

W. Martin Kast, C J Melief, J Curren et al.|Proceedings of the National Academy of Sciences|1991

Cited by 328